Pharma Journalist - Page 787 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

FDA concedes Glooko’s Mobile Insulin Dosing System

Bristol-Myers Squibb and Nektar Therapeutics collaborate commercially for NKTR-214

OTTR partners Hemasoft to facilitate transfusion medicine

IRX Therapeutics commences Phase 2 Clinical Trial for CIN3 or VIN3 women

Neurocrine Biosciences files NDA for opicapone for Parkinson’s disease

Sandoz asserts FDA’s approval for initiation of Glatopa

FDA clearance sought for Roche’s Factor II and Factor V test on cobas 4800 system

FDA sanctions breakthrough treatment for specific kind of Prostate Cancer

J&J Pharmaceuticals announce approval of ERLEADA by FDA for NM-CRPC patients

Mallinckrodt affirms enlisting of first patient for ExpressGraft C9T1 Phase 1 Study